TRIF mediates toll-like receptor 2-dependent inflammatory responses to borrelia burgdorferi

Infection and Immunity

Volumn 81, Issue 2, 2013, Pages 402-410

  Petnicki Ocwieja, Tanja ^a   Chung, Erin ^a   Acosta, David I ^b   Ramos, Laurie T ^b   Shin, Ok S ^a   Ghosh, Sanjukta ^c   Kobzik, Lester ^c   Li, Xin ^b   Hua, Linden T ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 10; INTERLEUKIN 6; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIAL LOAD; BONE MARROW CELL; BORRELIA BURGDORFERI; CELL DENSITY; CONTROLLED STUDY; CYTOKINE RESPONSE; INTERFERON INDUCTION; INTRACELLULAR SPACE; LYME DISEASE; MACROPHAGE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; BORRELIA BURGDORFERI; INFLAMMATION; INTERFERON TYPE I; LIGANDS; LYME DISEASE; MICE; MICE, INBRED C57BL; MYELOID DIFFERENTIATION FACTOR 88; PHAGOCYTOSIS; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2;

EID: 84873054924     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00890-12     Document Type: Article

References (59)

1. Shin OS, Isberg RR, Akira S, Uematsu S, Behera AK, Hu LT. 2008. Distinct roles for MyD88 and Toll-like receptors 2, 5, and 9 in phagocytosis of Borrelia burgdorferi and cytokine induction. Infect. Immun. 76: 2341-2351.
2. Salazar JC, Duhnam-Ems S, La Vake C, Cruz AR, Moore MW, Caimano MJ, Velez-Climent L, Shupe J, Krueger W, Radolf JD. 2009. Activation of human monocytes by live Borrelia burgdorferi generates TLR2-dependent and -independent responses which include induction of IFN-β. PLoS Pathog. 5:e1000444. doi:10.1371/journal.ppat.1000444.
3. Cervantes JL, Dunham-Ems SM, La Vake CJ, Petzke MM, Sahay B, Sellati TJ, Radolf JD, Salazar JC. 2011. Phagosomal signaling by Borrelia burgdorferi in human monocytes involves Toll-like receptor (TLR) 2 and TLR8 cooperativity and TLR8-mediated induction of IFN-beta. Proc. Natl. Acad. Sci. U. S. A. 108:3683-3688.
4. Petzke MM, Brooks A, Krupna MA, Mordue D, Schwartz I. 2009. Recognition of Borrelia burgdorferi, the Lyme disease spirochete, by TLR7 and TLR9 induces a type I IFN response by human immune cells. J. Immunol. 183:5279 -5292.
5. Wooten RM, Ma Y, Yoder RA, Brown JP, Weis JH, Zachary JF, Kirschning CJ, Weis JJ. 2002. Toll-like receptor 2 is required for innate, but not acquired, host defense to Borrelia burgdorferi. J. Immunol. 168: 348-355.
6. Wooten RM, Ma Y, Yoder RA, Brown JP, Weis JH, Zachary JF, Kirschning CJ, Weis JJ. 2002. Toll-like receptor 2 plays a pivotal role in host defense and inflammatory response to Borrelia burgdorferi. Vector Borne Zoonotic Dis. 2:275-278.
7. Hirschfeld M, Kirschning CJ, Schwandner R, Wesche H, Weis JH, Wooten RM, Weis JJ. 1999. Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by Toll-like receptor 2. J. Immunol. 163:2382-2386.
8. Fikrig E, Narasimhan S, Neelakanta G, Pal U, Chen M, Flavell R. 2009. Toll-like receptors 1 and 2 heterodimers alter Borrelia burgdorferi gene expression in mice and ticks. J. Infect. Dis. 200:1331-1340.
9. Cassiani-Ingoni R, Cabral ES, Lunemann JD, Garza Z, Magnus T, Gelderblom H, Munson PJ, Marques A, Martin R. 2006. Borrelia burgdorferi induces TLR1 and TLR2 in human microglia and peripheral blood monocytes but differentially regulates HLA-class II expression. J. Neuropathol. Exp. Neurol. 65:540 -548.
10. Alexopoulou L, Thomas V, Schnare M, Lobet Y, Anguita J, Schoen RT, Medzhitov R, Fikrig E, Flavell RA. 2002. Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2- deficient mice. Nat. Med. 8:878-884.
11. Bolz DD, Sundsbak RS, Ma Y, Akira S, Kirschning CJ, Zachary JF, Weis JH, Weis JJ. 2004. MyD88 plays a unique role in host defense but not arthritis development in Lyme disease. J. Immunol. 173:2003-2010.
12. Liu N, Montgomery RR, Barthold SW, Bockenstedt LK. 2004. Myeloid differentiation antigen 88 deficiency impairs pathogen clearance but does not alter inflammation in Borrelia burgdorferi-infected mice. Infect. Immun. 72:3195-3203.
13. Kawai T, Akira S. 2011. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34:637- 650.
14. Kagan JC, Su T, Horng T, Chow A, Akira S, Medzhitov R. 2008. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferonbeta. Nat. Immunol. 9:361-368.
15. Oshiumi H, Matsumoto M, Funami K, Akazawa T, Seya T. 2003. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat. Immunol. 4:161-167.
16. Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H, Takeuchi O, Sugiyama M, Okabe M, Takeda K, Akira S. 2003. Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science 301:640-643.
17. Yamamoto M, Sato S, Mori K, Hoshino K, Takeuchi O, Takeda K, Akira S. 2002. Cutting edge: a novel Toll/IL-1 receptor domaincontaining adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J. Immunol. 169:6668-6672.
18. Kawai T, Akira S. 2009. The roles of TLRs, RLRs, and NLRs in pathogen recognition. Int. Immunol. 21:317-337.
19. Toshchakov V, Jones BW, Perera PY, Thomas K, Cody MJ, Zhang S, Williams BR, Major J, Hamilton TA, Fenton MJ, Vogel SN. 2002. TLR4, but not TLR2, mediates IFN-β-induced STAT1α/β-dependent gene expression in macrophages. Nat. Immunol. 3:392-398.
20. Takeuchi O, Kaufmann A, Grote K, Kawai T, Hoshino K, Morr M, Muhlradt PF, Akira S. 2000. Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide- 2 activates immune cells through a Toll-like receptor 2- and MyD88- dependent signaling pathway. J. Immunol. 164:554 -557.
21. Barbalat R, Lau L, Locksley RM, Barton GM. 2009. Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands. Nat. Immunol. 10:1200 -1207.
22. Dieterich R, Hammerschmidt C, Richter D, Skerka C, Wallich R, Matuschka FR, Zipfel PF, Kraiczy P. 2010. Inadequate binding of immune regulator factorHis associated with sensitivity of Borrelia lusitaniae to human complement. Infect. Immun. 78:4467- 4476.
23. Marre ML, Petnicki-Ocwieja T, Defrancesco AS, Darcy CT, Hu LT. 2010. Human integrin α3β1 regulates TLR2 recognition of lipopeptides from endosomal compartments. PLoS One 5:e12871. doi:10.1371/journal.pone.0012871.
24. Ip WK, Sokolovska A, Charriere GM, Boyer L, Dejardin S, Cappillino MP, Yantosca LM, Takahashi K, Moore KJ, Lacy-Hulbert A, Stuart LM. 2010. Phagocytosis and phagosome acidification are required for pathogen processing and MyD88-dependent responses to Staphylococcus aureus. J. Immunol. 184:7071-7081.
25. Ip WKE, Takahashi K, Moore KJ, Stuart LM, Ezekowitz RAB. 2008. Mannose-binding lectin enhances Toll-like receptors 2 and 6 signaling from the phagosome. J. Exp. Med. 205:169 -181.
26. Dietrich N, Lienenklaus S, Weiss S, Gekara NO. 2010. Murine Toll-like receptor 2 activation induces type I interferon responses from endolysosomal compartments. PLoS One 5:e10250. doi:10.1371/journal.pone.0010250.
27. Shin OS, Miller LS, Modlin RL, Akira S, Uematsu S, Hu LT. 2009. Downstream signals for MyD88-mediated phagocytosis of Borrelia burgdorferi can be initiated by TRIF and are dependent on PI3K. J. Immunol. 183:491- 498.
28. Cruz AR, Moore MW, La Vake CJ, Eggers CH, Salazar JC, Radolf JD. 2008. Phagocytosis of Borrelia burgdorferi, the Lyme disease spirochete, potentiates innate immune activation and induces apoptosis in human monocytes. Infect. Immun. 76:56 -70.
29. Moore MW, Cruz AR, LaVake CJ, Marzo AL, Eggers CH, Salazar JC, Radolf JD. 2007. Phagocytosis of Borrelia burgdorferi and Treponema pallidum potentiates innate immune activation and induces gamma interferon production. Infect. Immun. 75:2046 -2062.
30. Adachi O, Kawai T, Takeda M, Matsumoto M, Tsutsui H, Sakagami K, Nakanishi K, Akira S. 1998. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9:143.
31. Ghosh S, Gregory D, Smith A, Kobzik L. 2011. MARCO regulates early inflammatory responses against influenza: a useful macrophage function with adverse outcome. Am. J. Respir. Cell Mol. Biol. doi:10.1165/rcmb.2010-0349OC.
32. Purser JE, Norris SJ. 2000. Correlation between plasmid content and infectivity in Borrelia burgdorferi. Proc. Natl. Acad. Sci. U. S. A. 97:13865- 13870.
33. Petnicki-Ocwieja T, DeFrancesco AS, Chung E, Darcy CT, Bronson RT, Kobayashi KS, Hu LT. 2011. Nod2 suppresses Borrelia burgdorferi mediated murine Lyme arthritis and carditis through the induction of tolerance. PLoS One 6:e17414. doi:10.1371/journal.pone.0017414.
34. Marie I, Durbin JE, Levy DE. 1998. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J. 17:6660-6669.
35. Li X, Liu X, Beck DS, Kantor FS, Fikrig E. 2006. Borrelia burgdorferi lacking BBK32, a fibronectin-binding protein, retains full pathogenicity. Infect. Immun. 74:3305-3313.
36. Aubry C, Corr SC, Wienerroither S, Goulard C, Jones R, Jamieson AM, Decker T, O'Neill LA, Dussurget O, Cossart P. 2012. Both TLR2 and TRIF contribute to interferon-beta production during Listeria infection. PLoS One 7:e33299. doi:10.1371/journal.pone.0033299.
37. Miller JC, Ma Y, Bian J, Sheehan KC, Zachary JF, Weis JH, Schreiber RD, Weis JJ. 2008. A critical role for type I IFN in arthritis development following Borrelia burgdorferi infection of mice. J. Immunol. 181:8492- 8503.
38. Miller JC, Maylor-Hagen H, Ma Y, Weis JH, Weis JJ. 2010. The Lyme disease spirochete Borrelia burgdorferi utilizes multiple ligands, including RNA, for interferon regulatory factor 3-dependent induction of type I interferon-responsive genes. Infect. Immun. 78:3144 -3153.
39. Behera AK, Hildebrand E, Bronson RT, Perides G, Uematsu S, Akira S, Hu LT. 2006. MyD88 deficiency results in tissue-specific changes in cytokine induction and inflammation in interleukin-18-independent mice infected with Borrelia burgdorferi. Infect. Immun. 74:1462-1470.
40. Oosting M, van de Veerdonk FL, Kanneganti TD, Sturm P, Verschueren I, Berende A, van der Meer JW, Kullberg BJ, Netea MG, Joosten LA. 2011. Borrelia species induce inflammasome activation and IL-17 production through a caspase-1-dependent mechanism. Eur. J. Immunol. 41:172-181.
41. Liu N, Belperron AA, Booth CJ, Bockenstedt LK. 2009. The caspase 1 inflammasome is not required for control of murine Lyme borreliosis. Infect. Immun. 77:3320 -3327.
42. Petnicki-Ocwieja T, Hrncir T, Liu YJ, Biswas A, Hudcovic T, Tlaskalova- Hogenova H, Kobayashi KS. 2009. Nod2 is required for the regulation of commensal microbiota in the intestine. Proc. Natl. Acad. Sci. U. S. A. 106:15813-15818.
43. Zhu Q, Egelston C, Vivekanandhan A, Uematsu S, Akira S, Klinman DM, Belyakov IM, Berzofsky JA. 2008. Toll-like receptor ligands synergize through distinct dendritic cell pathways to induce T cell responses: implications for vaccines. Proc. Natl. Acad. Sci. U. S. A. 105:16260 -16265.
44. Ouyang X, Negishi H, Takeda R, Fujita Y, Taniguchi T, Honda K. 2007. Cooperation between MyD88 and TRIF pathways in TLR synergy via IRF5 activation. Biochem. Biophys. Res. Commun. 354:1045-1051.
45. Hoebe K, Du X, Georgel P, Janssen E, Tabeta K, Kim SO, Goode J, Lin P, Mann N, Mudd S, Crozat K, Sovath S, Han J, Beutler B. 2003. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 424:743-748.
46. Lien E, Sellati TJ, Yoshimura A, Flo TH, Rawadi G, Finberg RW, Carroll JD, Espevik T, Ingalls RR, Radolf JD, Golenbock DT. 1999. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J. Biol. Chem. 274:33419 -33425.
47. Behera AK, Hildebrand E, Uematsu S, Akira S, Coburn J, Hu LT. 2006. Identification of a TLR-independent pathway for Borrelia burgdorferiinduced expression of matrix metalloproteinases and inflammatory mediators through binding to integrin alpha 3 beta 1. J. Immunol. 177:657- 664.
48. Sahay B, Patsey RL, Eggers CH, Salazar JC, Radolf JD, Sellati TJ. 2009. CD14 signaling restrains chronic inflammation through induction of p38-MAPK/SOCS-dependent tolerance. PLoS Pathog. 5:e1000687. doi:10.1371/journal.ppat.1000687.
49. -/- mice. FEMS Immunol. Med. Microbiol. 52:124 -133.
50. Mukhopadhyay S, Varin A, Chen Y, Liu B, Tryggvason K, Gordon S. 2011. SR-A/MARCO-mediated ligand delivery enhances intracellular TLR and NLR function, but ligand scavenging from cell surface limits TLR4 response to pathogens. Blood 117:1319 -1328.
51. Bowdish DM, Sakamoto K, Kim MJ, Kroos M, Mukhopadhyay S, Leifer CA, Tryggvason K, Gordon S, Russell DG. 2009. MARCO, TLR2, and CD14 are required for macrophage cytokine responses to mycobacterial trehalose dimycolate and Mycobacterium tuberculosis. PLoS Pathog. 5:e1000474. doi:10.1371/journal.ppat.1000474.
52. Hsu HY, Twu YC. 2000. Tumor necrosis factor-alpha-mediated protein kinases in regulation of scavenger receptor and foam cell formation on macrophage. J. Biol. Chem. 275:41035- 41048.
53. Hsu HY, Nicholson AC, Hajjar DP. 1996. Inhibition of macrophage scavenger receptor activity by tumor necrosis factor-alpha is transcriptionally and posttranscriptionally regulated. J. Biol. Chem. 271:7767- 7773.
54. Zamora C, Canto E, Nieto JC, Angels Ortiz M, Juarez C, Vidal S. 2012. Functional consequences of CD36 downregulation by TLR signals. Cytokine doi:10.1016/j.cyto.2012.06.020.
55. Sahay B, Singh A, Gnanamani A, Patsey RL, Blalock JE, Sellati TJ. 2011. CD14 signaling reciprocally controls collagen deposition and turnover to regulate the development of Lyme arthritis. Am. J. Pathol. 178:724 -734.
56. Biswas SK, Lopez-Collazo E. 2009. Endotoxin tolerance: new mechanisms, molecules, and clinical significance. Trends Immunol. 30:475- 487.
57. Qureshi ST, Lariviere L, Leveque G, Clermont S, Moore KJ, Gros P, Malo D. 1999. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J. Exp. Med. 189:615- 625.
58. Kawai T, Adachi O, Ogawa T, Takeda K, Akira S. 1999. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11:115-122.
59. Kobayashi K, Hernandez LD, Galan JE, Jr, Medzhitov R, Flavell RA. 2002. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110:191-202.